RxDoctor Payments DataLook up a doctor →

Caren Arnette

Primary Care · Dillon, SCNPI 1912163064

Payments from drug & device makers

$7,257in general payments, 2019–2025

Across 459 payments — averaging $15.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novartis$573
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$481
  • Merck$380
  • Abbott$375
  • Lilly USA, LLC$330
  • plus $4K from 43 others

What the payments were for

  • Food & beverage$7,246100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,257 in reported general payments places this provider in the 90th percentile of 115 primary care providers in South Carolina.

See all primary care providers in South Carolina

Medicare billing

Part B allowed, 2024
$26,332
Medicare patients
72
Services billed
725

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide30$40,434
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$31,970
JardianceEmpagliflozin31$31,638
MounjaroTirzepatide15$15,744
OzempicSemaglutide13$11,838
EliquisApixaban14$9,039
Breo ElliptaFluticasone/Vilanterol15$8,252
LinzessLinaclotide12$6,762
NexletolBempedoic Acid11$4,212
Dexlansoprazole DrDexlansoprazole11$3,675
Omeprazole105$1,555
Rosuvastatin Calcium80$1,555
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$1,531
Atorvastatin Calcium174$1,412
Albuterol Sulfate HfaAlbuterol Sulfate28$1,236

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$330$56,17745 claims
GSKTrelegy Ellipta, Breo Ellipta$324$40,22247 claims
Boehringer IngelheimJardiance$167$31,63831 claims
Novo NordiskOzempic$78$11,83813 claims
PfizerEliquis$308$9,03914 claims
AbbVieLinzess$1,589$6,76212 claims
Esperion Therapeutics, Inc.Nexletol$128$4,21211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 115 primary care providers in South Carolina.

Other primary care in Dillon

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →